Cryotherapy for Breast Cancer Trial
The purpose of this study is to evaluate the clinical feasibility and safety of the ICESENSE3TM cryotherapy system for the ablation of small malignant invasive breast tumors.
Breast Carcinoma
DEVICE: Ice-Sense3TM
The rate of complete tumor ablation in patients treated with cryoablation, with complete tumor ablation defined as no remaining invasive or in-situ carcinoma present upon pathological examination of the surgical resection specimen, One month
Adverse events, To describe the adverse events associated with cryoablation in these patients., One month|Pain assessment, To prospectively gather pain assessment data before and after cryoablation and after surgical resection in these patients, One month
The purpose of this study is to evaluate the clinical feasibility and safety of the ICESENSE3TM cryotherapy system for the ablation of small malignant invasive breast tumors.